Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...

Roughly 10 weeks ago, Christi Grimm was the inspector general and top watchdog monitoring the Department of Health and Human ...

In February, a panel of three judges in the U.S. Court of Appeals for the First Circuit issued a decision in United States v.

Regeneron is the second pharma group to sign up for access to data from a remote study run by health technology firm Koneksa that is exploring the use of digital biomarkers to track patients with ...